EUVIMEDEUVIMED entdecken
Crossref

Use of Eutoplac for the Prevention of Septic Complications in Post-Bariatric Patients Undergoing Body Contouring Surgery

Claudio Ligresti, Luca Patanè

Journal of Surgery Research and Practice · 05.06.2026 · 7 (2) · 1-9

DOI: 10.46889/jsrp.2026.7207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgery Research and Practice, online erschienen am 05.06.2026. Verfasst von Claudio Ligresti und 1 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post-bariatric body-contouring surgery carries a 20-45% risk of minor wound-healing disorders and Surgical-Site Infection (SSI) despite standard peri-operative antibiotic prophylaxis. Disruption of the cutaneous microbiome is increasingly recognised as an independent risk factor for SSI and topical probiotics can restore eubiosis and enhance infection protection. We evaluated whether a 7-day pre-operative course of EUTOPLAC® a topical blend of Lactobacillus crispatus P17631 and Lacticaseibacillus paracasei I1688 (TOPLAC® mixture) improves early wound outcomes in post-bariatric patients scheduled for body-contouring surgery.

Methods

In this single-centre, parallel-group pilot study, 25 female post-bariatric patients applied for seven days before surgery one squeezable capsule of EUTOPLAC daily to the future incision zone on the right side only, leaving the contralateral side untreated (self-control design). Clinical signs (erythema, oedema, pain, burning, pruritus, bleeding, dryness) were graded 0 – 3 at surgery (V1), day 7 (V2) and day 23 (V3). Primary outcome was the proportion of signs rated ≤ 1 (absent/light); secondary outcomes were adverse events and tolerability.

Results

Across all visits, treated wounds showed significantly higher proportions of absent/light scores than untreated counterparts. At V3, moderate-severe erythema persisted in 84% of untreated sites but only 4% of treated sites. Similar advantages were observed for burning (72% vs. 4%) and pruritus (64% vs. 16%). Perilesional skin mirrored these trends, with treated areas maintaining ≥ 98% scores ≤ 1 at V3. No probiotic-related adverse events occurred.

Conclusion

Seven-day topical pre-habilitation with EUTOPLAC markedly reduced early inflammatory and septic cutaneous complications without side effects. These findings support the concept that restoring the skin microbiome before incision is a feasible, antimicrobic-sparing adjunct to current SSI-prevention bundles. Larger randomised trials are warranted to confirm efficacy and to explore mechanistic links between probiotic colonisation, innate immunity and scar quality.

Zitieren

APA

Ligresti, C., & Patanè, L. (2026). Use of Eutoplac for the Prevention of Septic Complications in Post-Bariatric Patients Undergoing Body Contouring Surgery. Journal of Surgery Research and Practice, 7(2), 1-9. https://doi.org/10.46889/jsrp.2026.7207

Vancouver

Ligresti C, Patanè L. Use of Eutoplac for the Prevention of Septic Complications in Post-Bariatric Patients Undergoing Body Contouring Surgery. Journal of Surgery Research and Practice. 2026;7(2):1-9. doi:10.46889/jsrp.2026.7207

BibTeX
@article{Ligresti2026,
  author = {Ligresti, Claudio and Patanè, Luca},
  title = {Use of Eutoplac for the Prevention of Septic Complications in Post-Bariatric Patients Undergoing Body Contouring Surgery},
  journal = {Journal of Surgery Research and Practice},
  year = {2026},
  volume = {7},
  number = {2},
  pages = {1--9},
  doi = {10.46889/jsrp.2026.7207}
}
Kostenlos starten →